These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902 [TBL] [Abstract][Full Text] [Related]
3. Detection of autoantibody against extracellular epitopes of N-methyl-D-aspartate receptor by cell-based assay. Takano S; Takahashi Y; Kishi H; Taguchi Y; Takashima S; Tanaka K; Muraguchi A; Mori H Neurosci Res; 2011 Nov; 71(3):294-302. PubMed ID: 21839784 [TBL] [Abstract][Full Text] [Related]
4. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482 [TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric autoimmune encephalitis without VGKC-complex, NMDAR, and GAD autoantibodies: case report and literature review. Najjar S; Pearlman D; Devinsky O; Najjar A; Nadkarni S; Butler T; Zagzag D Cogn Behav Neurol; 2013 Mar; 26(1):36-49. PubMed ID: 23538571 [TBL] [Abstract][Full Text] [Related]
7. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076 [TBL] [Abstract][Full Text] [Related]
8. Autoimmune causes of encephalitis syndrome in Thailand: prospective study of 103 patients. Saraya A; Mahavihakanont A; Shuangshoti S; Sittidetboripat N; Deesudchit T; Callahan M; Wacharapluesadee S; Wilde H; Hemachudha T BMC Neurol; 2013 Oct; 13():150. PubMed ID: 24139084 [TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and differential diagnosis of anti-N-methyl-D-aspartate receptor encephalitis in children]. Wang H Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jun; 16(6):578-83. PubMed ID: 24927431 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Dale RC; Merheb V; Pillai S; Wang D; Cantrill L; Murphy TK; Ben-Pazi H; Varadkar S; Aumann TD; Horne MK; Church AJ; Fath T; Brilot F Brain; 2012 Nov; 135(Pt 11):3453-68. PubMed ID: 23065479 [TBL] [Abstract][Full Text] [Related]
12. Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome. Bien CG; Bien CI; Dogan Onugoren M; De Simoni D; Eigler V; Haensch CA; Holtkamp M; Ismail FS; Kurthen M; Melzer N; Mayer K; von Podewils F; Rauschka H; Rossetti AO; Schäbitz WR; Simova O; Witt K; Höftberger R; May TW J Neurol; 2020 Jul; 267(7):2101-2114. PubMed ID: 32246252 [TBL] [Abstract][Full Text] [Related]
13. [Autoimmune encephalitis: possibilities in the laboratory investigation]. Böröcz K; Hayden Z; Mészáros V; Csizmadia Z; Farkas K; Kellermayer Z; Balogh P; Nagy F; Berki T Orv Hetil; 2018 Jan; 159(3):107-112. PubMed ID: 29332416 [TBL] [Abstract][Full Text] [Related]
14. Anti-N-methyl-D-aspartate receptor encephalitis: a common cause of encephalitis in the intensive care unit. Chen X; Li JM; Liu F; Wang Q; Zhou D; Lai X Neurol Sci; 2016 Dec; 37(12):1993-1998. PubMed ID: 27620725 [TBL] [Abstract][Full Text] [Related]
15. Characterisation of a syndrome of autoimmune adult onset focal epilepsy and encephalitis. Ramanathan S; Bleasel A; Parratt J; Orr C; Dale RC; Vincent A; Fung VS J Clin Neurosci; 2014 Jul; 21(7):1169-75. PubMed ID: 24518268 [TBL] [Abstract][Full Text] [Related]
16. Analysis of relapses in anti-NMDAR encephalitis. Gabilondo I; Saiz A; Galán L; González V; Jadraque R; Sabater L; Sans A; Sempere A; Vela A; Villalobos F; Viñals M; Villoslada P; Graus F Neurology; 2011 Sep; 77(10):996-9. PubMed ID: 21865579 [TBL] [Abstract][Full Text] [Related]
17. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Armangue T; Spatola M; Vlagea A; Mattozzi S; Cárceles-Cordon M; Martinez-Heras E; Llufriu S; Muchart J; Erro ME; Abraira L; Moris G; Monros-Giménez L; Corral-Corral Í; Montejo C; Toledo M; Bataller L; Secondi G; Ariño H; Martínez-Hernández E; Juan M; Marcos MA; Alsina L; Saiz A; Rosenfeld MR; Graus F; Dalmau J; Lancet Neurol; 2018 Sep; 17(9):760-772. PubMed ID: 30049614 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis. Malter MP; Elger CE; Surges R Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046 [TBL] [Abstract][Full Text] [Related]